Virus entry inhibition by chlorite-oxidized oxyamylose versus induction of antiviral interferon by poly(I:C)

Biochemical Pharmacology

Volumn 76, Issue 7, 2008, Pages 831-840

  Li, Sandra ^a   Martens, Erik ^a   Dillen, Chris ^a   Van den Steen, Philippe E ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral; COAM; Entry inhibition; Interferon; Polyanion; Polysaccharide

Indexed keywords

ALPHA INTERFERON; AMYLOSE; ANTIVIRUS AGENT; BETA INTERFERON; CHLORITE OXIDIZED AMYLOSE; HELICASE; INTERFERON; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; SODIUM CHLORITE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG MECHANISM; FIBROBLAST; INFECTION PREVENTION; MENGO VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION;

AMYLOSE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; INTERFERON-ALPHA; INTERFERON-BETA; MENGOVIRUS; MICE; POLY I-C; RNA, MESSENGER; RNA, VIRAL; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 51249123090     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.07.022     Document Type: Article

References (38)

1. Karpas A., Fleet G.W., Dwek R.A., Petursson S., Namgoong S.K., Ramsden N.G., et al. Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proc Natl Acad Sci USA 85 (1988) 9229-9233
2. Block T.M., Lu X., Platt F.M., Foster G.R., Gerlich W.H., Blumberg B.S., et al. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci USA 91 (1994) 2235-2239
3. Branza-Nichita N., Durantel D., Carrouee-Durantel S., Dwek R.A., and Zitzmann N. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers. J Virol 75 (2001) 3527-3536
4. Zitzmann N., Mehta A.S., Carrouee S., Butters T.D., Platt F.M., McCauley J., et al. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci USA 96 (1999) 11878-11882
5. Wu S.F., Lee C.J., Liao C.L., Dwek R.A., Zitzmann N., and Lin Y.L. Antiviral effects of an iminosugar derivative on flavivirus infections. J Virol 76 (2002) 3596-3604
6. Claes P., Billiau A., De Clercq E., Desmyter J., Schonne E., Vanderhaeghe H., et al. Polyacetal carboxylic acids: a new group of antiviral polyanions. J Virol 5 (1970) 313-320
7. Billiau A., Muyembe J.J., and De Somer P. Effect of chlorite-oxidized oxyamylose on influenza virus infection in mice. Appl Microbiol 21 (1971) 580-584
8. Leunen J., Desmyter J., and De Somer P. Effects of oxyamylose and polyacrylic acid on foot-and-mouth disease and hog cholera virus infections. Appl Microbiol 21 (1971) 203-208
9. Billiau A., Desmyter J., and De Somer P. Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid. J Virol 5 (1970) 321-328
10. De Clercq E., and Luczak M. Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs. J Infect Dis 133 Suppl (1976) A226-A236
11. Baba M., Snoeck R., Pauwels R., and De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother 32 (1988) 1742-1745
12. Hosoya M., Balzarini J., Shigeta S., and De Clercq E. Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins. Antimicrob Agents Chemother 35 (1991) 2515-2520
13. Lederman S., Gulick R., and Chess L. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J Immunol 143 (1989) 1149-1154
14. Weber F., Wagner V., Rasmussen S.B., Hartmann R., and Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80 (2006) 5059-5064
15. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413 (2001) 732-738
16. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
17. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 280 (2005) 5571-5580
18. Rudd B.D., Burstein E., Duckett C.S., Li X., and Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79 (2005) 3350-3357
19. Ashkar A.A., Yao X.D., Gill N., Sajic D., Patrick A.J., and Rosenthal K.L. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J Infect Dis 190 (2004) 1841-1849
20. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101 (2004) 3516-3521
21. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103 (2006) 8459-8464
22. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., and Fisher P.B. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA 99 (2002) 637-642
23. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 (2004) 730-737
24. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175 (2005) 2851-2858
25. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005) 19-28
26. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
27. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6 (2007) 975-990
28. Takaoka A., and Yanai H. Interferon signalling network in innate defence. Cell Microbiol 8 (2006) 907-922
29. Maes P., Li S., Verbeeck J., Keyaerts E., Clement J., and Van Ranst M. Evaluation of the efficacy of disinfectants against Puumala hantavirus by real-time RT-PCR. J Virol Methods 141 (2007) 111-115
30. Fronhoffs S., Totzke G., Stier S., Wernert N., Rothe M., Bruning T., et al. A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes 16 (2002) 99-110
31. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
32. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20 (1988) 309-321
33. Levy H.B., Duenwald J., and Buckler C.E. Chlorite-oxidized amylose as an adjuvant for interferon production. Infect Immun 7 (1973) 457-460
34. van Pesch V., Lanaya H., Renauld J.C., and Michiels T. Characterization of the murine alpha interferon gene family. J Virol 78 (2004) 8219-8228
35. Luscher-Mattli M. Polyanions-a lost chance in the fight against HIV and other virus diseases?. Antivir Chem Chemother 11 (2000) 249-259
36. Harmon M.W., Janis B., and Levy H.B. Post-exposure prophylaxis of murine rabies with polyinosinic-polycytidylic acid and chlorite-oxidized amylose. Antimicrob Agents Chemother 6 (1974) 507-511
37. Liebhaber H., and Takemoto K.K. The basis for the size differences in plaques produced by variants of encephalomyocarditis (EMC) virus. Virology 20 (1963) 559-566
38. Mandel B. Inhibition of Theiler's encephalomyelitis virus (GDVII strain) of mice by an intestinal mucopolysaccharide. III. Studies on factors that influence the virus-inhibitor reaction. Virology 3 (1957) 444-463